A Novel Method for Pathway Identification Based on Attractor and Crosstalk in Polyarticular Juvenile Idiopathic Arthritis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27804927)

Published in Med Sci Monit on November 02, 2016

Authors

Yuanji Wang1, Shunhua Lin1, Changhui Li1, Yizhao Li1, Lei Chen1, Yingzhen Wang2

Author Affiliations

1: Department of Orthopaedics, The People's Hospital of Rizhao, Rizhao, Shandong, China (mainland).
2: Department of Joint Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).

Articles cited by this

KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00

Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88

affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics (2004) 32.08

FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics (2004) 26.64

Controlling the false discovery rate in behavior genetics research. Behav Brain Res (2001) 21.82

STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res (2012) 18.26

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol (2004) 14.06

ArrayExpress--a public database of microarray experiments and gene expression profiles. Nucleic Acids Res (2006) 8.92

The P53 pathway: what questions remain to be explored? Cell Death Differ (2006) 4.91

Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. N Engl J Med (2012) 4.85

Tofacitinib versus methotrexate in rheumatoid arthritis. N Engl J Med (2014) 4.64

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial. Lancet (2013) 4.49

Calculating the statistical significance of changes in pathway activity from gene expression data. Stat Appl Genet Mol Biol (2004) 2.48

A global pathway crosstalk network. Bioinformatics (2008) 2.27

Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study. Arthritis Rheum (2013) 2.13

Identification of functional modules that correlate with phenotypic difference: the influence of network topology. Genome Biol (2010) 1.25

Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets. Arthritis Rheum (2009) 1.15

A proposal for using the ensemble approach to understand genetic regulatory networks. J Theor Biol (2004) 1.14

attract: A method for identifying core pathways that define cellular phenotypes. PLoS One (2011) 0.99

Juvenile idiopathic arthritis: a review for the pediatrician. Pediatr Rev (2006) 0.93

Immunological investigation in children with juvenile chronic arthritis. Med Sci Monit (2001) 0.86

Clinical analysis in 202 children with juvenile idiopathic arthritis. Clin Rheumatol (2013) 0.82

Crosstalk analysis of pathways in breast cancer using a network model based on overlapping differentially expressed genes. Exp Ther Med (2015) 0.82

Composition of phospholipid fatty acids in erythrocyte membranes of children with chronic juvenile arthritis: clinical and biochemical correlations. Med Sci Monit (2001) 0.80

A novel dysregulated pathway-identification analysis based on global influence of within-pathway effects and crosstalk between pathways. J R Soc Interface (2015) 0.80

Advances in the treatment of polyarticular juvenile idiopathic arthritis. Curr Opin Rheumatol (2015) 0.79

Spleen and liver enlargement in a patient with rheumatoid arthritis. Reumatol Clin (2014) 0.77

Is early TMJ involvement in children with juvenile idiopathic arthritis clinically detectable? Clinical examination of the TMJ in comparison with contrast enhanced MRI in patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J (2015) 0.77

[Expression and significance of interleukin-6, interferon-inducible protein-10 and interleukin-17 in serum and synovial fluid of patients with juvenile idiopathic arthritis]. Zhonghua Er Ke Za Zhi (2013) 0.77